MADHAVBAUG

Vaidya Sane Ayurved Laboratories Share Price

₹143.00 +6.2 (4.53%)

05 Nov, 2024 20:48

SIP TrendupStart SIP in MADHAVBAUG

Start SIP

Performance

  • Low
  • ₹137
  • High
  • ₹144
  • 52 Week Low
  • ₹107
  • 52 Week High
  • ₹309
  • Open Price₹137
  • Previous Close₹137
  • Volume1,600

Investment Returns

  • Over 1 Month + 5.15%
  • Over 3 Month + 5.93%
  • Over 6 Month -23.32%
  • Over 1 Year -51.36%
SIP Lightning

Smart Investing Starts Here Start SIP with Vaidya Sane Ayurved Laboratories for Steady Growth!

Vaidya Sane Ayurved Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • PEG Ratio
  • Market Cap Cr
  • 150
  • P/B Ratio
  • 2.7
  • Average True Range
  • 6.03
  • EPS
  • 0.9
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.92
  • RSI
  • 54.35
  • MFI
  • 58.91

Vaidya Sane Ayurved Laboratories Financial

IndicatorMar 24Mar 23
Revenue From Operations [Gross]97.3399.03
Revenue From Operations [Net]97.3399.03
Total Operating Revenues97.3399.03
Total Revenue98.89100.39
Total Expenses97.4493.48
Profit/Loss Before Tax1.456.91
Profit/Loss For The Period1.055.19
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-3.11-0.43
Net Cash Used In Investing Activity0.021.00
Net Cash Used in Finance Activity14.46-1.38
Net Inc/Dec In Cash And Equivalent11.37-0.81
Cash And Equivalent End Of Year13.121.75
IndicatorMar 24Mar 23
Total Share Capital10.5110.51
Total Non-Current Liabilities1.341.60
Total Current Liabilities15.0312.87
Total Capital And Liabilities71.3955.28
Total Non-Current Assets39.2026.46
Total Current Assets32.2028.82
Total Assets71.3955.28
Indicator20242023
EBIT Margin (%)1.747.16
Return On Capital Employed (%)3.0116.73
Return On Equity (%)1.8912.71
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)52.3438.82
IndicatorMar 24Mar 23
Revenue From Operations [Gross]99.3399.17
Revenue From Operations [Net]99.3399.17
Total Operating Revenues99.3399.17
Total Revenue101.08100.53
Total Expenses98.2294.10
Profit/Loss Before Tax2.866.43
Profit/Loss For The Period1.994.83
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-4.410.06
Net Cash Used In Investing Activity1.490.52
Net Cash Used in Finance Activity14.46-1.38
Net Inc/Dec In Cash And Equivalent11.55-0.80
Cash And Equivalent End Of Year13.311.76
IndicatorMar 24Mar 23
Total Share Capital10.5110.51
Total Non-Current Liabilities1.361.55
Total Current Liabilities13.9312.88
Total Capital And Liabilities70.8954.88
Total Non-Current Assets37.4327.10
Total Current Assets33.4727.78
Total Assets70.8954.88
Indicator20242023
EBIT Margin (%)3.136.67
Return On Capital Employed (%)5.4615.75
Return On Equity (%)3.5611.94
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)52.8938.48

Vaidya Sane Ayurved Laboratories Technicals

EMA & SMA

Current Price
₹143.00
+ 6.2 (4.53%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • ₹138.93
  • 50 Day
  • ₹142.11
  • 100 Day
  • ₹151.03
  • 200 Day
  • ₹171.59

Resistance and Support

141.25 Pivot Speed
  • R3 152.10
  • R2 147.90
  • R1 145.45
  • S1 138.80
  • S2 134.60
  • S3 132.15

Is Vaidya Sane Ayurved Laboratories Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vaidya Sane Ayurved Laboratories has an operating revenue of Rs. 198.50 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 3% needs improvement, ROE of 3% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Vaidya Sane Ayurved Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results & Others To consider other business matters.
2024-05-26 Audited Results
2023-05-27 Audited Results & Dividend
2022-11-10 Quarterly Results
Date Purpose Remarks
2022-11-18 INTERIM Declaration of Interim dividend at the rate of 0.25 per share {2.5%}.

Vaidya Sane Ayurved Laboratories F&O

Vaidya Sane Ayurved Laboratories Shareholding Pattern

66.34%
22.24%
11.42%
  • NSE Symbol
  • MADHAVBAUG
  • BSE Symbol
  • Managing Director
  • Dr. Rohit Madhav Sane
  • ISIN
  • INE0JR301013

Vaidya Sane Ayurved Laboratories FAQs

Vaidya Sane Ayurved Laboratories share price is ₹143 As on 05 November, 2024 | 20:34

The Market Cap of Vaidya Sane Ayurved Laboratories is ₹150.3 Cr As on 05 November, 2024 | 20:34

The P/E ratio of Vaidya Sane Ayurved Laboratories is As on 05 November, 2024 | 20:34

The PB ratio of Vaidya Sane Ayurved Laboratories is 2.7 As on 05 November, 2024 | 20:34

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form